Emerging roles of class I PI3K inhibitors in modulating tumor microenvironment and immunity

Overview of attention for article published in Acta Pharmacologica Sinica, September 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 33 publications that cite this research output.

33

The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.

Characteristics of the Colorectal Cancer Microenvironment—Role in Cancer Progression and Therapeutic Possibilities

Article in Applied Sciences (March 2024)

Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target

Article in Frontiers in Immunology (February 2024)

A Long Way to Go: A Scenario for Clinical Trials of PI3K Inhibitors in Treating Cancer

Article in Cancer Control (January 2024)